New Investigational Medication for patients with moderate to severe COPD (chronic obstructive pulmonary disease) - September 17, 2012
Investigational medication for pediatric patients with Autism, Asperger’s disorder, or Pervasive developmental disorder. - May 8, 2012
Newly approved medication for subjects in early stages of treatment for Relapsing Remitting Multiple Sclerosis - May 8, 2012
Protocol: F-AV-45-A17 PET scan using an investigational radioactive drug to help determine the likely cause of cognitive decline. - May 8, 2012
Protocol: DS5565-A-U201 New Investigational Medication for Diabetic Peripheral Neuropathy - May 8, 2012
Protocol: ROF-MD-07 New Investigational Medication for Severe Chronic Obstructive Pulmonary Disease (COPD) - May 8, 2012
Protocol: P07037 New Investigational Medication for Moderate to Severe Parkinson’s Disease - August 23, 2011
